NeuroD1 regulation of migration accompanies the differential sensitivity of neuroendocrine carcinomas to TrkB inhibition

J. K. Osborne, J. E. Larsen, J. X. Gonzales, D. S. Shames, M. Sato, I. I. Wistuba, L. Girard, J. D. Minna, M. H. Cobb

Research output: Contribution to journalArticle

9 Scopus citations


The developmental transcription factor NeuroD1 is anomalously expressed in a subset of aggressive neuroendocrine tumors. Previously, we demonstrated that TrkB and neural cell adhesion molecule (NCAM) are downstream targets of NeuroD1 that contribute to the actions of neurogenic differentiation 1 (NeuroD1) in neuroendocrine lung. We found that several malignant melanoma and prostate cell lines express NeuroD1 and TrkB. Inhibition of TrkB activity decreased invasion in several neuroendocrine pigmented melanoma but not in prostate cell lines. We also found that loss of the tumor suppressor p53 increased NeuroD1 expression in normal human bronchial epithelial cells and cancer cells with neuroendocrine features. Although we found that a major mechanism of action of NeuroD1 is by the regulation of TrkB, effective targeting of TrkB to inhibit invasion may depend on the cell of origin. These findings suggest that NeuroD1 is a lineage-dependent oncogene acting through its downstream target, TrkB, across multiple cancer types, which may provide new insights into the pathogenesis of neuroendocrine cancers.

Original languageEnglish (US)
Article numbere63
StatePublished - Sep 3 2013



  • NeuroD1
  • TrkB
  • migration
  • neuroendocrine

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research

Cite this